Healthcare provider profile · identity verified

Mark A Faruque, MD

Family Practice · TAYLORSVILLE, NC · NPI 1386764173

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	576	128
Levothyroxine Sodium	Levothyroxine Sodium	478	91
Amlodipine Besylate	Amlodipine Besylate	455	105
Rosuvastatin Calcium	Rosuvastatin Calcium	404	104
Omeprazole	Omeprazole	354	81
Losartan Potassium	Losartan Potassium	307	65
Lisinopril	Lisinopril	254	55
Hydrochlorothiazide	Hydrochlorothiazide	219	44
Potassium Chloride	Potassium Chloride	204	43
Pantoprazole Sodium	Pantoprazole Sodium	196	40
Lorazepam	Lorazepam	190	31
Metformin Hcl	Metformin Hcl	182	37
Gabapentin	Gabapentin	170	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	167	25
Furosemide	Furosemide	166	37
Simvastatin	Simvastatin	159	41
Tamsulosin Hcl	Tamsulosin Hcl	154	31
Duloxetine Hcl	Duloxetine Hcl	153	26
Glipizide Er	Glipizide	142	29
Metoprolol Succinate	Metoprolol Succinate	142	34
Sertraline Hcl	Sertraline Hcl	135	20
Clopidogrel	Clopidogrel Bisulfate	124	19
Fluticasone Propionate	Fluticasone Propionate	120	35
Montelukast Sodium	Montelukast Sodium	115	20
Celecoxib	Celecoxib	107	22
Allopurinol	Allopurinol	102	18
Meloxicam	Meloxicam	101	20
Tramadol Hcl	Tramadol Hcl	101	23
Albuterol Sulfate Hfa	Albuterol Sulfate	99	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	99	18
Metformin Hcl Er	Metformin Hcl	93	21
Metoprolol Tartrate	Metoprolol Tartrate	93	25
Jardiance	Empagliflozin	90	16
Alprazolam	Alprazolam	87	18
Zolpidem Tartrate	Zolpidem Tartrate	86	14
Pravastatin Sodium	Pravastatin Sodium	83	17
Ibandronate Sodium	Ibandronate Sodium	78	16
Trazodone Hcl	Trazodone Hcl	78	15
Clonazepam	Clonazepam	77	14
Citalopram Hbr	Citalopram Hydrobromide	75	20
Eliquis	Apixaban	75	17
Prednisone	Prednisone	75	37
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	72	suppressed
Hydralazine Hcl	Hydralazine Hcl	70	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	16
Spironolactone	Spironolactone	62	15
Escitalopram Oxalate	Escitalopram Oxalate	60	13
Pregabalin	Pregabalin	60	suppressed
Chlorthalidone	Chlorthalidone	58	11
Fenofibrate	Fenofibrate	58	12
Venlafaxine Hcl Er	Venlafaxine Hcl	58	suppressed
Carvedilol	Carvedilol	56	16
Donepezil Hcl	Donepezil Hcl	54	suppressed
Verapamil Er	Verapamil Hcl	54	suppressed
Alendronate Sodium	Alendronate Sodium	53	11
Tizanidine Hcl	Tizanidine Hcl	52	13
Ezetimibe	Ezetimibe	51	11
Benazepril Hcl	Benazepril Hcl	49	14
Esomeprazole Magnesium	Esomeprazole Magnesium	48	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	suppressed
Telmisartan	Telmisartan	46	suppressed
Diazepam	Diazepam	43	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	suppressed
Finasteride	Finasteride	42	suppressed
Ibuprofen	Ibuprofen	42	12
Ozempic	Semaglutide	42	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	40	suppressed
Ipratropium Bromide	Ipratropium Bromide	40	suppressed
Baclofen	Baclofen	39	suppressed
Famotidine	Famotidine	38	11
Mirtazapine	Mirtazapine	38	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Tresiba Flextouch U-100	Insulin Degludec	38	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Hydrocortisone	Hydrocortisone	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Ramipril	Ramipril	30	suppressed
Mounjaro	Tirzepatide	29	suppressed
Nebivolol Hcl	Nebivolol Hcl	28	suppressed
Glipizide	Glipizide	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	suppressed
Methotrexate	Methotrexate Sodium	24	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Crestor	Rosuvastatin Calcium	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Naproxen	Naproxen	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Etodolac	Etodolac	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Atenolol	Atenolol	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Bumetanide	Bumetanide	17	suppressed
Cephalexin	Cephalexin	17	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Nystatin	Nystatin	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	13
Fosinopril Sodium	Fosinopril Sodium	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Cefdinir	Cefdinir	12	12
Gemfibrozil	Gemfibrozil	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nadolol	Nadolol	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	11	suppressed
Cartia Xt	Diltiazem Hcl	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Levoxyl	Levothyroxine Sodium	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Ssd	Silver Sulfadiazine	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Testosterone	Testosterone	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error